The voice-based agentic AI outfit's tech is impressive, but winning enough customers is proving challenging. There's an ...

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from ...

After years of a regulatory ESG tsunami, the ESG wave broke in 2025. With ESG backlash and the cutting of “red tape” in the EU, 2025 ...

New automation possibilities offered by AI may change intrinsic properties of cyber risks. Cyber insurance has been seen as a crucial tool in cybersecurity for two reasons: First, insurance against ...

Key points Shaped like the Australian coastline, the Australia Magnetic Anomaly is a concealed magnetic geological feature ...

Six companies dominate nearly all U.S. media: Comcast, Disney, Warner Bros., Paramount, Sony, and Amazon. Comcast serves as the largest pay-TV and home internet provider in the U.S. Warner Bros. and ...

As highlighted by Kotaku, The Verge's Jay Peters – who has been given early access to the tool – has gleefully posted that he was able to "generate a bunch of Nintendo-inspired games. Including one ...

Having largely been a South Africa-based company with a few exports here and there, under the leadership of new CEO Freddy Mugeri, Hydro Power Equipment (HPE) is aiming for global expansion. In a ...

Objective Concentration of care and collaborations between hospitals increasingly reorganise oncological care into Comprehensive Cancer Networks (CCNs), aiming to improve care outcomes and reduce ...

Jan 30 (Reuters) - Global drugmakers are ramping up U.S. manufacturing and stockpiling inventory as the Trump administration considers a 100% tariff on imported branded and patented medicines.